Cargando…
Drug resistance: from bacteria to cancer
The phenomenon of drug resistance has been a hindrance to therapeutic medicine since the late 1940s. There is a plethora of factors and mechanisms contributing to progression of drug resistance. From prokaryotes to complex cancers, drug resistance is a prevailing issue in clinical medicine. Although...
Autores principales: | Patel, Harsh, Wu, Zhuo-Xun, Chen, Yanglu, Bo, Letao, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607383/ https://www.ncbi.nlm.nih.gov/pubmed/35006446 http://dx.doi.org/10.1186/s43556-021-00041-4 |
Ejemplares similares
-
Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line
por: Wu, Zhuo-Xun, et al.
Publicado: (2021) -
The Battlefield of Chemotherapy in Pediatric Cancers
por: Bo, Letao, et al.
Publicado: (2023) -
Overexpression of ABCC1 Confers Drug Resistance to Betulin
por: Chen, Xuan-Yu, et al.
Publicado: (2021) -
Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic Bacteria
por: Kong, Jing, et al.
Publicado: (2020) -
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
por: Zhang, Lei, et al.
Publicado: (2023)